4.53 USD
↗ 0.40 (9.69%)AT CLOSE (11:59 AM EDT)
SELLAS Life Sciences Group, Inc. Common Stock
SLSNASDAQ • USD
4.54
↘ 0.01 (0.13%)
POST MARKET (AS OF 05:02 PM EDT)
Post Market
AS OF 05:02 PM EDT
4.54
↘ 0.01 (0.13%)
Market: OPEN
Open?$4.24
High?$4.66
Low?$4.20
Prev. Close?$4.13
Volume?5.3M
Avg. Volume?8.1M
VWAP?$4.50
Rel. Volume?0.65x
Bid / Ask
Bid?$3.85 × 100
Ask?$5.16 × 100
Spread?$1.31
Midpoint?$4.51
Valuation & Ratios
Market Cap?741.7M
Shares Out?179.6M
Float?147.9M
Float %?98.7%
P/E Ratio?N/A
P/B Ratio?10.47
EPS?-$0.15
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?10.70Strong
Quick Ratio?10.70Strong
Cash Ratio?10.23Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUED
Score67/100
P/E?N/A▾
P/B?10.47HIGH▾
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-23.7CHEAP▾
EV/Sales?N/A▾
Returns & Efficiency
ROE?-37.9%WEAK▾
ROA?-34.3%WEAK▾
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$669.9M
Related Companies
Loading...
News
Profile
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.
Employees
13
Market Cap
741.7M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2008-03-12
Address
7 TIMES SQUARE
NEW YORK, NY 10036
Phone: (646) 200-5278
NEW YORK, NY 10036
Phone: (646) 200-5278